162 related articles for article (PubMed ID: 38461190)
1. Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier.
Grasedieck S; Panahi A; Jarvis MC; Borzooee F; Harris RS; Larijani M; Avet-Loiseau H; Samur M; Munshi N; Song K; Rouhi A; Kuchenbauer F
Leukemia; 2024 May; 38(5):1172-1177. PubMed ID: 38461190
[TBL] [Abstract][Full Text] [Related]
2. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.
Maura F; Petljak M; Lionetti M; Cifola I; Liang W; Pinatel E; Alexandrov LB; Fullam A; Martincorena I; Dawson KJ; Angelopoulos N; Samur MK; Szalat R; Zamora J; Tarpey P; Davies H; Corradini P; Anderson KC; Minvielle S; Neri A; Avet-Loiseau H; Keats J; Campbell PJ; Munshi NC; Bolli N
Leukemia; 2018 Apr; 32(4):1044-1048. PubMed ID: 29209044
[No Abstract] [Full Text] [Related]
3. Mutational processes contributing to the development of multiple myeloma.
Hoang PH; Cornish AJ; Dobbins SE; Kaiser M; Houlston RS
Blood Cancer J; 2019 Aug; 9(8):60. PubMed ID: 31387987
[TBL] [Abstract][Full Text] [Related]
4. Molecular origins of APOBEC-associated mutations in cancer.
Petljak M; Maciejowski J
DNA Repair (Amst); 2020 Oct; 94():102905. PubMed ID: 32818816
[TBL] [Abstract][Full Text] [Related]
5. AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
Svoboda M; Meshcheryakova A; Heinze G; Jaritz M; Pils D; Castillo-Tong DC; Hager G; Thalhammer T; Jensen-Jarolim E; Birner P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Zimmermann P; Zeillinger R; Mechtcheriakova D
BMC Genomics; 2016 Aug; 17(1):643. PubMed ID: 27527602
[TBL] [Abstract][Full Text] [Related]
6. Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
Messerschmidt C; Obermayer B; Klinghammer K; Ochsenreither S; Treue D; Stenzinger A; Glimm H; Fröhling S; Kindler T; Brandts CH; Schulze-Osthoff K; Weichert W; Tinhofer I; Klauschen F; Keilholz U; Beule D; Rieke DT
Int J Cancer; 2020 Oct; 147(8):2293-2302. PubMed ID: 32468570
[TBL] [Abstract][Full Text] [Related]
7. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP
Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs regulate APOBEC gene expression.
Cao W; Wu W
Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.
Wang S; Jia M; He Z; Liu XS
Oncogene; 2018 Jul; 37(29):3924-3936. PubMed ID: 29695832
[TBL] [Abstract][Full Text] [Related]
10. APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.
DiMarco AV; Qin X; McKinney BJ; Garcia NMG; Van Alsten SC; Mendes EA; Force J; Hanks BA; Troester MA; Owzar K; Xie J; Alvarez JV
Cancer Immunol Res; 2022 Jan; 10(1):70-86. PubMed ID: 34795033
[TBL] [Abstract][Full Text] [Related]
11. APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy.
Sammons S; Raskina K; Danziger N; Alder L; Schrock AB; Venstrom JM; Knutson KL; Thompson EA; McGregor K; Sokol E; Chumsri S
JCO Precis Oncol; 2022 Oct; 6():e2200149. PubMed ID: 36315915
[TBL] [Abstract][Full Text] [Related]
12. [Interplay between HIV-1 and APOBEC].
Sato K; Koyanagi Y
Seikagaku; 2016; 88(5):569-75. PubMed ID: 29624319
[No Abstract] [Full Text] [Related]
13. [Hepatitis B virus and APOBEC family].
Muramatsu M; Kitamura K; Wakae K
Seikagaku; 2016 Oct; 88(5):557-62. PubMed ID: 29624316
[No Abstract] [Full Text] [Related]
14. HPV Meets APOBEC: New Players in Head and Neck Cancer.
Riva G; Albano C; Gugliesi F; Pasquero S; Pacheco SFC; Pecorari G; Landolfo S; Biolatti M; Dell'Oste V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573337
[TBL] [Abstract][Full Text] [Related]
15. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
Boyle EM; Deshpande S; Tytarenko R; Ashby C; Wang Y; Bauer MA; Johnson SK; Wardell CP; Thanendrarajan S; Zangari M; Facon T; Dumontet C; Barlogie B; Arbini A; Rustad EH; Maura F; Landgren O; Zhan F; van Rhee F; Schinke C; Davies FE; Morgan GJ; Walker BA
Nat Commun; 2021 Jan; 12(1):293. PubMed ID: 33436579
[TBL] [Abstract][Full Text] [Related]
16. High expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma.
Bernardini G; Vulpis E; Bonanni V; Stabile H; Ricciardi MR; Petrucci MT; Gismondi A; Santoni A; Zingoni A
Leuk Lymphoma; 2017 Oct; 58(10):2493-2496. PubMed ID: 28278706
[No Abstract] [Full Text] [Related]
17. Haematological cancer: Redefining myeloma.
Rajkumar SV; Merlini G; San Miguel JF
Nat Rev Clin Oncol; 2012 Sep; 9(9):494-6. PubMed ID: 22850755
[No Abstract] [Full Text] [Related]
18. APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma.
Faden DL; Kuhs KAL; Lin M; Langenbucher A; Pinheiro M; Yeager M; Cullen M; Boland JF; Steinberg M; Bass S; Lewis JS; Lawrence MS; Ferris RL; Mirabello L
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452530
[TBL] [Abstract][Full Text] [Related]
19. APOBECs and Herpesviruses.
Cheng AZ; Moraes SN; Shaban NM; Fanunza E; Bierle CJ; Southern PJ; Bresnahan WA; Rice SA; Harris RS
Viruses; 2021 Feb; 13(3):. PubMed ID: 33671095
[TBL] [Abstract][Full Text] [Related]
20. The TOLL of inflammation in multiple myeloma.
Bell JK
Cancer Biol Ther; 2011 Jan; 11(1):68-70. PubMed ID: 21099352
[No Abstract] [Full Text] [Related]
[Next] [New Search]